Life-Space Activities Are Associated with the Prognosis of Older Adults with Cardiovascular Disease
- PMID: 36286275
- PMCID: PMC9604436
- DOI: 10.3390/jcdd9100323
Life-Space Activities Are Associated with the Prognosis of Older Adults with Cardiovascular Disease
Abstract
Life-space activities are a measure of daily activity level. Here, we examined the association between life-space activities and prognosis in 129 cardiovascular diseases (CVD) patients 65 years of age or older (average age, 79.2 ± 7.6 years; mean left ventricular ejection fraction, 56.7 ± 13.2%) who had been admitted to our hospital for worsening CVD. Subjects were followed, and the primary endpoints were cardiovascular hospitalization and cardiovascular death. Receiver operating characteristic analysis produced a cutoff value for life-space assessment (LSA) score for increased risk of cardiovascular hospitalization for two years of 53.0 points (sensitivity, 55.9%; specificity, 82.1%). Kaplan−Meier analysis using this cutoff value revealed that the rates of cardiovascular hospitalization and cardiovascular death were significantly higher in subjects with an LSA score below the cutoff than in those with a score above the cutoff (both p < 0.001). Cox proportional analysis revealed that low LSA score was independently associated with cardiovascular hospitalization (HR, 2.540; 95% CI, 1.135−5.680; p = 0.023) and cardiovascular death (HR, 15.223; 95% CI, 1.689−137.180; p = 0.015), even after adjusting for age, sex, left ventricular ejection fraction, and log-transformed brain natriuretic peptide level. Thus, life-space activities are associated with prognosis in older adults with CVD.
Keywords: cardiovascular disease; cardiovascular events; heart failure; life-space activities; life-space assessment; older adult patient.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Short physical performance battery score and driving a car are independent factors associated with life-space activities in older adults with cardiovascular disease.Geriatr Gerontol Int. 2021 Oct;21(10):900-906. doi: 10.1111/ggi.14254. Epub 2021 Aug 6. Geriatr Gerontol Int. 2021. PMID: 34363304
-
H2FPEF Score as a Prognostic Value in HFpEF Patients.Am J Hypertens. 2019 Oct 16;32(11):1082-1090. doi: 10.1093/ajh/hpz108. Am J Hypertens. 2019. PMID: 31271191
-
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.JAMA Cardiol. 2018 Oct 1;3(10):1000-1005. doi: 10.1001/jamacardio.2018.2568. JAMA Cardiol. 2018. PMID: 30140899 Free PMC article. Clinical Trial.
-
Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol. 2009 Jan 1;103(1):73-5. doi: 10.1016/j.amjcard.2008.08.045. Epub 2008 Oct 17. Am J Cardiol. 2009. PMID: 19101233
-
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.Circulation. 2018 Jan 16;137(3):286-297. doi: 10.1161/CIRCULATIONAHA.117.031560. Circulation. 2018. PMID: 29335288
Cited by
-
Prevalence and correlates of restricted community mobility in a population-based cohort of adults with systemic lupus erythematosus.Lupus Sci Med. 2025 Mar 28;12(1):e001430. doi: 10.1136/lupus-2024-001430. Lupus Sci Med. 2025. PMID: 40154963 Free PMC article.
References
-
- Ministry of Health, L.A.W Statistics and Information Department. Vital Statistics. [(accessed on 15 February 2022)]. Available online: https://www.mhlw.go.jp/toukei/list/10-20.html.
-
- Tsao C.W., Aday A.W., Almarzooq Z.I., Alonso A., Beaton A.Z., Bittencourt M.S., Boehme A.K., Buxton A.E., Carson A.P., Commodore-Mensah Y., et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145:e153–e639. doi: 10.1161/CIR.0000000000001052. - DOI - PubMed
-
- Bekfani T., Pellicori P., Morris D.A., Ebner N., Valentova M., Steinbeck L., Wachter R., Elsner S., Sliziuk V., Schefold J.C., et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. Int. J. Cardiol. 2016;222:41–46. doi: 10.1016/j.ijcard.2016.07.135. - DOI - PubMed
LinkOut - more resources
Full Text Sources